Doxazosin mesylate and Toprol-xl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Doxazosin mesylate and Toprol-xl. Common interactions include asthenia among females and weight decreased among males.

The phase IV clinical study analyzes what interactions people who take Doxazosin mesylate and Toprol-xl have. It is created by eHealthMe based on reports of 90 people who take Doxazosin mesylate and Toprol-xl from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 04, 2022

90 people who take Doxazosin mesylate and Toprol-xl together, and have interactions are studied.


What is Doxazosin mesylate?

Doxazosin mesylate has active ingredients of doxazosin mesylate. It is often used in high blood pressure. eHealthMe is studying from 10,736 Doxazosin mesylate users for its effectiveness, alternative drugs and more.

What is Toprol-xl?

Toprol-xl has active ingredients of metoprolol succinate. It is often used in high blood pressure. eHealthMe is studying from 40,572 Toprol-xl users for its effectiveness, alternative drugs and more.

Number of Doxazosin mesylate and Toprol-xl reports submitted per year:

Doxazosin mesylate and Toprol-xl drug interactions.

Common Doxazosin Mesylate and Toprol-Xl drug interactions by gender *:

female:

  1. Asthenia
  2. Blood glucose increased
  3. Carpal tunnel syndrome
  4. Cellulitis
  5. Chest pain
  6. Cough
  7. Diarrhoea
  8. Fall
  9. Gait disturbance
  10. Haematochezia

male:

  1. Weight decreased
  2. Cardiac failure congestive
  3. Diarrhoea
  4. Dysphagia
  5. Haemoptysis
  6. Pneumonia aspiration
  7. Pneumonia primary atypical
  8. Nausea
  9. Oedema peripheral
  10. Osteonecrosis

Common Doxazosin Mesylate and Toprol-Xl drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Asthma
  2. Central nervous system lesion
  3. Depression
  4. Extremity contracture
  5. Fatigue
  6. Joint contracture
  7. Joint stiffness
  8. Memory impairment
  9. Mobility decreased
  10. Muscle tightness

40-49:

  1. Blood glucose increased
  2. Drug ineffective
  3. Angina unstable
  4. Ankle fracture
  5. Blood cholesterol increased
  6. Blood triglycerides increased
  7. Cardiac disorder
  8. Cardiac failure congestive
  9. Coronary artery disease
  10. Decreased appetite

50-59:

  1. Blood glucose decreased
  2. Cardiac failure congestive
  3. Cardiac hypertrophy
  4. Convulsion
  5. Deformity
  6. Drug ineffective
  7. Fatigue
  8. Fibrosis
  9. Flushing
  10. General physical health deterioration

60+:

  1. Weight decreased
  2. Anaemia
  3. Pneumonia aspiration
  4. Pneumonia primary atypical
  5. Ventricular extrasystoles
  6. Chest pain
  7. Dizziness
  8. Nausea
  9. Sinusitis
  10. Anxiety

Common conditions people have *:

  1. High Blood Cholesterol: 18 people, 20.00%
  2. Arrhythmias (irregular heartbeat): 14 people, 15.56%
  3. Osteoporosis (bones weak and more likely to break): 13 people, 14.44%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 10.00%
  5. Enlarged Prostate: 7 people, 7.78%
  6. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 7 people, 7.78%
  7. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 6 people, 6.67%
  8. Type 2 Diabetes: 5 people, 5.56%
  9. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 5.56%
  10. Pain: 5 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Doxazosin mesylate and Toprol-xl?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Doxazosin mesylate and Toprol-xl interactions:

Browse all drug interactions of Doxazosin mesylate and Toprol-xl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Doxazosin mesylate interactions:

Browse all interactions between Doxazosin mesylate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Toprol-xl interactions:

Browse all interactions between Toprol-xl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on doxazosin mesylate and metoprolol succinate (the active ingredients of Doxazosin mesylate and Toprol-xl, respectively), and Doxazosin mesylate and Toprol-xl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Doxazosin mesylate and Toprol-xl.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: